[ad_1]
Priority to those over 70, seriously ill and caregivers. Rezza: 240 thousand injections a day, normal in 7-13 months. Tomorrow yes to J&J, rumors of delays resized: in Italy 6.5 million doses for April 3
by Marzio Bartoloni
Priority to those over 70, seriously ill and caregivers. Rezza: 240 thousand injections a day, normal in 7-13 months. Tomorrow yes to J&J, rumors of delays resized: in Italy 6.5 million doses for April 3
3 ‘reading
First of all, the raw material: if all goes well, there will be just over 43 million doses between April and June. Triple the first three months, a dowry enough to try to triple the rate of injections, going from 100,000 to 300,000 per day. According to Gianni Rezza, director of the Ministry of Health, if we proceed with at least 240 thousand vaccinations “we will return to normality in 7-13 months”. Then we need vaccinators: after the half-failure of the announcement by former Commissioner Arcuri who hired 7,300 workers (4,600 doctors and only 2,500 nurses) and the bureaucracy (agreements are lacking in half the regions) to involve the 40 thousand family doctors, including Those reluctant to participate, the search for vaccinators for the massive campaign to be launched in April has begun.
And the tipping point could come from an outsider audience of more than 300,000 operators: mostly young doctors and nurses already working in hospitals and to whom to pay overtime, but the dentists. New forces in which the Ministry of Health increasingly intends to take advantage of to start the second phase.
Loading…
The unknowns are certainly not lacking: news broke yesterday of a delay in deliveries of Johnson & Johnson’s new single-dose serum, to which the EMA will give the green light on Thursday. However, the American company assured at night that will keep its commitments to the EU Italy will already supply 6.5 million doses at the beginning of April, which will be added to the 36.8 million of the other companies in June. “I’m not worried about the goal we have for the second quarter. We know that some will do better and others will be late, “EU Internal Market Commissioner Thierry Breton explained yesterday, adding that” the EU has many avenues available if something goes wrong. The reference is the block on the export of doses produced in the EU as already happened with those of AstraZeneca.
Covid, the data and the map
Real-time vaccines
